# Post Marketing Surveillance Study of Cuprimine

> **NCT01374282** · — · NO_LONGER_AVAILABLE · sponsor: **Merck Sharp & Dohme LLC**

## Conditions studied

- Scleroderma

## Interventions

- **DRUG:** Cuprimine (penicillamine)

## Key facts

- **NCT ID:** NCT01374282
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01374282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01374282, "Post Marketing Surveillance Study of Cuprimine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01374282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*